Course handouts are now available
Click here
Come to London
WATCH to find out why
Site updates:
Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.
Posters
(results will display both Free Papers & Poster)
Effect of goniosynechialysis during phacoemulsification on IOP in patients with medically well-controlled chronic angle closure glaucoma
Poster Details
First Author: C.Lee SOUTH KOREA
Co Author(s): C. Kim D. Kim
Abstract Details
Purpose:
To evaluate and compare the efficacy and safety of combined phacoemulsification and goniosynechialysis (PEGS) to phacoemulsification alone (PE) in patients with medically well controlled chronic angle closure glaucoma (CACG) with cataracts.
Setting:
Retrospective chart review
Methods:
Thirty eyes diagnosed with CACG and requiring cataract surgery from January 2008 to October 2010 were prospectively randomized, 15 each to PE and PEGS. Changes in peripheral anterior synechiae (PAS), intraocular pressure (IOP), anterior chamber depth (ACD) and number of anti-glaucoma drugs from baseline to two months after the operation were analyzed, as were the type and number of complications.
Results:
The PE group showed decreases in PAS (118.67 ± 95.38°) and IOP (2.33 ± 2.38 mmHg) and a significant reduction in the number of anti-glaucoma drugs (0.53 ± 0.83, P<0.05) from before to two months after surgery. The PEGS group showed similar decreases in PAS (114.00 ± 90.95°), and IOP(4.53 ± 4.16 mmHg) and number of anti-glaucoma drugs (1.20 ± 1.32)(P <0.05). However, the amount of decline in both groups did not show any significantly difference in PAS, reduction of IOP, or number of anti-glaucoma drugs (P >0.05), The increase in ACD from baseline to two months after surgery was significantly greater in the PEGS group (P =0.003).
Conclusions:
The IOP-lowering effects of PEGS do not differ significantly from those of PE in medically well-controlled CACG patients with cataract. These results suggest that additional goniosynechialysis during phacoemulsification is not necessary in such patients. FINANCIAL INTEREST: NONE